Login / Signup

[Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study)].

V V MashinL A BelovaE Y KotovaD R DolgovaA P StateninaY K BelyaevaA S DergachevaR R Israfilova
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
The results of the study allow us to recommend the complex prescription of Cortexin 10 mg/day for 10 days and Neuromexol tablets 125 mg (375-750 mg/day) for 30 days for chronic CVD. Complex therapy with Cortexin and Neuromexol is effective and safe in patients with CCI and CI.
Keyphrases
  • cognitive impairment
  • randomized controlled trial
  • clinical trial
  • quality improvement
  • bone marrow
  • smoking cessation